| Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and … K Brudey, JR Driscoll, L Rigouts, WM Prodinger, A Gori, SA Al-Hajoj, ... BMC microbiology 6, 1-17, 2006 | 1399 | 2006 |
| Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis MR Farhat, BJ Shapiro, KJ Kieser, R Sultana, KR Jacobson, TC Victor, ... Nature genetics 45 (10), 1183-1189, 2013 | 503 | 2013 |
| Patients with active tuberculosis often have different strains in the same sputum specimen RM Warren, TC Victor, EM Streicher, M Richardson, N Beyers, ... American journal of respiratory and critical care medicine 169 (5), 610-614, 2004 | 405 | 2004 |
| Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ... American journal of respiratory and critical care medicine 184 (1), 132-140, 2011 | 401 | 2011 |
| Drug resistance in Mycobacterium tuberculosis R Johnson, EM Streicher, GE Louw, RM Warren, PD Van Helden, ... Current issues in molecular biology 8 (2), 97-112, 2006 | 387 | 2006 |
| Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa M Klopper, RM Warren, C Hayes, NCG van Pittius, EM Streicher, B Müller, ... Emerging infectious diseases 19 (3), 449, 2013 | 339 | 2013 |
| Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis F Coll, J Phelan, GA Hill-Cawthorne, MB Nair, K Mallard, S Ali, ... Nature genetics 50 (2), 307-316, 2018 | 335 | 2018 |
| Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study K Dheda, K Shean, A Zumla, M Badri, EM Streicher, L Page-Shipp, ... The Lancet 375 (9728), 1798-1807, 2010 | 316 | 2010 |
| Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study E Pietersen, E Ignatius, EM Streicher, B Mastrapa, X Padanilam, A Pooran, ... The Lancet 383 (9924), 1230-1239, 2014 | 301 | 2014 |
| A Recently Evolved Sublineage of the Mycobacterium tuberculosis Beijing Strain Family Is Associated with an Increased Ability to Spread and Cause Disease M Hanekom, GD Van Der Spuy, E Streicher, SL Ndabambi, CRE McEvoy, ... Journal of clinical microbiology 45 (5), 1483-1490, 2007 | 286 | 2007 |
| Microevolution of the Direct Repeat Region of Mycobacterium tuberculosis: Implications for Interpretation of Spoligotyping Data RM Warren, EM Streicher, SL Sampson, GD Van Der Spuy, M Richardson, ... Journal of Clinical Microbiology 40 (12), 4457-4465, 2002 | 200 | 2002 |
| Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa AD Calver, M Murray, OJ Strauss, EM Streicher, M Hanekom, T Liversage, ... Emerging infectious diseases 16 (2), 264, 2010 | 198 | 2010 |
| A global perspective on pyrazinamide resistance: systematic review and meta-analysis MG Whitfield, HM Soeters, RM Warren, T York, SL Sampson, EM Streicher, ... PloS one 10 (7), e0133869, 2015 | 166 | 2015 |
| Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value MR Farhat, R Sultana, O Iartchouk, S Bozeman, J Galagan, P Sisk, ... American journal of respiratory and critical care medicine 194 (5), 621-630, 2016 | 156 | 2016 |
| Spoligotype Signatures in the Mycobacterium tuberculosis Complex EM Streicher, TC Victor, G Van Der Spuy, C Sola, N Rastogi, ... Journal of clinical microbiology 45 (1), 237-240, 2007 | 154 | 2007 |
| gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis FA Sirgel, RM Warren, EM Streicher, TC Victor, PD van Helden, ... Journal of antimicrobial chemotherapy 67 (5), 1088-1093, 2012 | 150 | 2012 |
| Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable … K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ... The lancet Respiratory medicine 5 (4), 269-281, 2017 | 148 | 2017 |
| Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis S Borrell, Y Teo, F Giardina, EM Streicher, M Klopper, J Feldmann, ... Evolution, medicine, and public health 2013 (1), 65-74, 2013 | 142 | 2013 |
| Detection and quantification of differentially culturable tubercle bacteria in sputum from patients with tuberculosis MD Chengalroyen, GM Beukes, BG Gordhan, EM Streicher, ... American journal of respiratory and critical care medicine 194 (12), 1532-1540, 2016 | 132 | 2016 |
| Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa K Shean, E Streicher, E Pieterson, G Symons, R van Zyl Smit, G Theron, ... PloS one 8 (5), e63057, 2013 | 123 | 2013 |
Robin M WarrenStellenbosch UniversityVerified email at sun.ac.za
